Hudson Executive Capital LP, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 28,038 shares at $60.16 ($1.7M) on 2019-10-10, disclosed to the SEC on 2019-10-15.
Open-market sale of $1.7M EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.16 | 7,829 | $471K | 27.7% |
| 2 | $60.39 | 16,300 | $984K | 57.9% |
| 3 | $62.63 | 3,909 | $245K | 14.4% |
| Total | $60.64 avg | 28,038 | $1.7M | 100% |
| Filing → |
| CATM | BUY | 2020-06-29 | $8.6M | — | Filing → |
| CATM | BUY | 2020-06-23 | $8.2M | — | Filing → |
| CATM | BUY | 2020-05-19 | $1.5M | — | Filing → |